/
IRIX
$0.84+$0.02 (+1.93%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$15.1M
17M shares
52-week range
$0.80 – $1.65
4% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
CS
Change$-6.64
Iridex Corp
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
www.iridex.com- Employees
- 108
- IPO / List date
- Feb 16, 1996
- HQ
- MOUNTAIN VIEW, CA
Held by traders on TradeandTell
No one on the platform currently holds IRIX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 396,627 | $400.6K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded IRIX yet.
